- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration.
September 21, 2019
[Robot-assisted laparoscopic partial nephrectomy].
September 21, 2019
CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma
September 20, 2019
Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinoma.
September 20, 2019
Chronic effects of repeated low dose cisplatin treatment in mouse kidneys and renal tubular cells.
September 20, 2019
A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-Deficient Renal Cell Carcinoma in 32 Patients.
September 18, 2019
Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer.
September 17, 2019
Racial/ethnic disparities in renal cell carcinoma: Increased risk of early-onset and variation in histologic subtypes.
September 13, 2019
Measuring Tumor Mutational Burden Using Whole-Exome Sequencing.
September 12, 2019
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis.
September 12, 2019
Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma.
September 12, 2019
MicroRNA-96 is a potential tumor repressor by inhibiting NPTX2 in renal cell carcinoma.
September 11, 2019
A Pedunculated Skin Lesion in a Case of Clear Cell Renal Carcinoma.
September 11, 2019
MicroRNA-30a-3p functions as a tumor suppressor in renal cell carcinoma by targeting WNT2.
September 11, 2019
Solitary fibrous tumor of the kidney: A case report.
September 10, 2019
Paraneoplastic syndromes and oncological outcomes in renal cancer.
September 10, 2019